These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37318)
1. Dissolution systems for chloramphenicol tablet bioavailability. Ogata H; Shibazaki T; Inoue T; Ejima A J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318 [TBL] [Abstract][Full Text] [Related]
2. Effect of food on bioavailability of nalidixic acid from uncoated tablets having different dissolution rates. Ogata H; Aoyagi N; Kaniwa N; Ejima A J Pharmacobiodyn; 1984 Oct; 7(10):760-7. PubMed ID: 6520698 [TBL] [Abstract][Full Text] [Related]
3. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials. Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124 [TBL] [Abstract][Full Text] [Related]
4. Effect of food on bioavailability of metronidazole from sugar-coated tablets having different dissolution rates in subjects with low gastric acidity. Ogata H; Aoyagi N; Kaniwa N; Ejima A Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):279-82. PubMed ID: 3733276 [TBL] [Abstract][Full Text] [Related]
5. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs. Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141 [TBL] [Abstract][Full Text] [Related]
6. Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet. Ogata H; Shibazaki T; Inoue T; Ejima A J Pharm Sci; 1979 Jun; 68(6):708-12. PubMed ID: 458569 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets. Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086 [TBL] [Abstract][Full Text] [Related]
8. Comparative bioavailability of josamycin, a macrolide antibiotic, from a tablet and solution and the influence of dissolution on in vivo release. Skinner M; Kanfer I Biopharm Drug Dispos; 1998 Jan; 19(1):21-9. PubMed ID: 9510982 [TBL] [Abstract][Full Text] [Related]
9. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects. Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804 [TBL] [Abstract][Full Text] [Related]
10. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations. Rasool BK; Fahmy SA; Galeel OW Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine. Jantratid E; Prakongpan S; Amidon GL; Dressman JB Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285 [TBL] [Abstract][Full Text] [Related]
12. Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms. Chemburkar PB; Smyth RD; Buehler JD; Shah PB; Joslin RS; Polk A; Reavey-Cantwell NH J Pharm Sci; 1976 Apr; 65(4):529-33. PubMed ID: 1271252 [TBL] [Abstract][Full Text] [Related]
13. The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel. Kaniwa N; Ogata H; Aoyagi N; Ejima A J Pharmacobiodyn; 1982 Mar; 5(3):187-92. PubMed ID: 7097486 [TBL] [Abstract][Full Text] [Related]
14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
15. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets. Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345 [TBL] [Abstract][Full Text] [Related]
16. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid. Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Fahmy RH; Kassem MA Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390 [TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of levomycetin preparations for oral use]. Batuashvili TA; Zak AF Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263 [TBL] [Abstract][Full Text] [Related]
19. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates. Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147 [TBL] [Abstract][Full Text] [Related]
20. Relationship between dissolution rate and bioavailability of paracetamol tablet. Huang XP; Wan XX; Liu Q Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]